Browse treatments

…spitalisations, disease damage (per SLICC/ACR Damage Index) and pharmacologic treatments were assessed. Outcomes during the 4-year extension were compar…

… inflammatory arthritis and primarily affects the joints. While therapeutic advances have substantially reduced the risk of long-term disability, co…

…ion of the primary lung tumour site. The LCT may be expanded to locoregional therapy and involve systematic lymph node dissection or lobe-specific l…

…gions continues to hinder progress in liver disease prevention, treatment, and policy reform.…

…ts aged 40–65 years within 10 years of T2D diagnosis and not on insulin therapy will be enrolled. Both intervention arms will receive an 800–90…

…on infectious disease management (52.3%, n=22/42), particularly HIV treatments (42.8%, n=18/42), followed by mental health medications (23.8%,…

…ers noting different forms of violence faced by patients during cancer therapy.Conclusion Findings underscore the pressing need to prioritise …

… and jejunal loop dilation and the ECG returned to normal after gastric decompression. Although several mechanisms might be implicated, our findings …

…aturation antigen (BCMA) was recently identified as a target of T-cell-directed therapy for acute myeloid leukemia (AML), based on the study reporting …

…as the lead operator.2 There is only one other surgical option, liver transplantation, described only 4 years after Kasai’s paper by Starzl et al. in…

…rcoma with clear margins. Given the limited evidence supporting adjuvant therapy in low-grade disease, surgery alone was appropriate, and the pa…

… As for systemic therapy, intravenous bevacizumab combined with chemotherapy has demonstrated clinical benefits in NSCLC patients. However, …